The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ubs Oncology Impact Fund L.p. since 2017.
This trader's CIK number is 1691428.
At the time of last reporting, Ubs Oncology Impact Fund L.p. was the Officer of Iteos Therapeutics, Inc.. (stock ticker symbol ITOS).
Also see all insider trading activities at Iteos Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | SNSS | 81,500 | $226,001 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ITOS | 0 | $0 | 1,031,931 | $8,317,363 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HARP | 0 | $0 | 422,620 | $8,893,846 | 0 | $0 |
1. Viracta Therapeutics, Inc. (SNSS)
2. Iteos Therapeutics, Inc. (ITOS)
3. Harpoon Therapeutics, Inc. (HARP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-02 | SNSS | Buy | 25,300 | 2.59 | 65,527 |
| 2017-11-03 | SNSS | Buy | 40,000 | 2.89 | 115,600 |
| 2017-11-06 | SNSS | Buy | 16,200 | 2.77 | 44,874 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-13 | ITOS | Sale | 1,031,931 | 8.06 | 8,317,363 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-26 | HARP | Sale | 3,198 | 20.04 | 64,087 |
| 2021-05-27 | HARP | Sale | 13,961 | 20.26 | 282,849 |
| 2021-05-21 | HARP | Sale | 10,907 | 20.21 | 220,430 |
| 2021-05-24 | HARP | Sale | 5,000 | 20.12 | 100,600 |
| 2021-05-20 | HARP | Sale | 11,713 | 20.34 | 238,242 |
| 2021-05-19 | HARP | Sale | 17,833 | 20.39 | 363,614 |
| 2021-05-18 | HARP | Sale | 18,402 | 20.67 | 380,369 |
| 2021-05-17 | HARP | Sale | 4,666 | 20.07 | 93,646 |
| 2021-05-13 | HARP | Sale | 4,855 | 20.06 | 97,391 |
| 2021-05-14 | HARP | Sale | 6,900 | 20.04 | 138,276 |
| 2021-05-10 | HARP | Sale | 17,133 | 22.12 | 378,981 |
| 2021-05-11 | HARP | Sale | 21,445 | 21.23 | 455,384 |
| 2021-05-12 | HARP | Sale | 29,684 | 20.53 | 609,412 |
| 2021-05-05 | HARP | Sale | 10,172 | 22.80 | 231,972 |
| 2021-04-27 | HARP | Sale | 11,829 | 21.12 | 249,887 |
| 2021-04-28 | HARP | Sale | 51,022 | 21.82 | 1,113,555 |
| 2021-04-29 | HARP | Sale | 67,292 | 22.28 | 1,499,265 |
| 2021-04-21 | HARP | Sale | 8,972 | 19.21 | 172,352 |
| 2021-04-16 | HARP | Sale | 5,847 | 20.19 | 118,050 |
| 2021-04-19 | HARP | Sale | 10,056 | 19.68 | 197,952 |
| 2021-04-20 | HARP | Sale | 22,249 | 18.89 | 420,394 |
| 2021-04-15 | HARP | Sale | 8,696 | 20.49 | 178,181 |
| 2021-04-14 | HARP | Sale | 13,806 | 20.45 | 282,263 |
| 2021-04-13 | HARP | Sale | 16,054 | 19.71 | 316,504 |
| 2021-04-09 | HARP | Sale | 10,300 | 23.67 | 243,801 |
| 2021-04-12 | HARP | Sale | 20,628 | 21.64 | 446,389 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ubs Oncology Impact Fund L.p. (Officer of Iteos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.